Prevalence (%)* | % of total costs† | % as most cost-incurring condition‡ | % most cost-incurring/prevalence§ | % of costs by most cost-incurring condition¶ | |
N17-N19 Renal failure | 12.2 | 6.8 | 6.4 | 52.4 | 66.0 |
C81-C96 Leukaemia | 5.6 | 3.0 | 4.1 | 74.3 | 41.4 |
C15-C26 Malignant neoplasms of digestive organs | 7.5 | 2.4 | 5.4 | 71.2 | 47.9 |
I60-I69 Cerebrovascular diseases | 7.9 | 2.1 | 4.2 | 53.1 | 52.7 |
I70-I79 Diseases of arteries, arterioles and capillaries | 9.6 | 2.0 | 4.1 | 42.7 | 47.3 |
C30-C39 Lung cancer | 5.9 | 1.7 | 3.5 | 59.1 | 52.5 |
I51-I52 Complications/ill-defined descriptions, other heart disorders | 9.6 | 1.6 | 3.2 | 33.1 | 50.3 |
I44–I49 Atrial fibrillation, rhythm and conduction disorders | 11.8 | 1.6 | 2.9 | 24.3 | 58.5 |
I20-I25 Ischaemic heart diseases | 12.7 | 1.6 | 3.7 | 29.0 | 41.9 |
I50 Heart failure | 9.3 | 1.5 | 2.6 | 28.4 | 57.1 |
*Prevalence of each ICD-10 subchapter among top 1% beneficiaries. For example, 12.2% of top 1% beneficiaries were treated for renal failure.
†Sum of total treatment costs per ICD-10 subchapter. For example, treatment of renal failure accounted for 6.8% of total expenditures of top 1% beneficiaries.
‡Percentage of top 1% with this ICD-10 subchapter as most cost-incurring condition. For example, 6.4% of top 1% beneficiaries had renal failure as most cost-incurring condition.
§Percentage most cost-incurring condition relative to prevalence: fourth column divided by second column. For example, for 52.4% of top 1% beneficiaries who were treated for renal failure, this was also their most cost-incurring condition.
¶Percentage of costs accounted for by the most cost-incurring condition. For example, among top 1% beneficiaries with renal failure as most cost-incurring condition, this disease accounted for on average 66% of total costs per beneficiary.